Veterans Affairs Peer Review Neutrality Act of 2025
Summary
HB6519, titled the Veterans Affairs Peer Review Neutrality Act of 2025, would amend title 38 of the U.S. Code to reduce conflicts of interest in Veterans Health Administration quality management and investigative processes. The bill requires individuals conducting peer review to step aside if they were directly involved in the care under review or cannot provide an objective, impartial, accurate, and informed review. It also directs VA medical facilities to create procedures so that an initial peer review involving a provider who sits on the peer review committee is reviewed by a neutral committee at another VA facility.
The bill further tightens rules for administrative investigation boards and factfinders. It bars people with knowledge of confidential quality assurance information about the matter from serving on or briefing those bodies, and it requires the Secretary to ensure board members and factfinders have no personal bias, direct involvement, or supervisory/personal relationship with the subject of the investigation. Potential members must disclose disqualifying conflicts and recuse themselves. The bill adds a new section to chapter 73 of title 38 and makes a conforming table-of-sections amendment.
Impact
If enacted, the bill would create new statutory requirements governing VA peer review, administrative investigations, and factfinding related to quality management of care at VA medical facilities. It would expand recusal and neutrality standards, require cross-facility review in certain cases, and formalize conflict-of-interest safeguards in the Veterans Health Administration’s internal oversight processes. The affected parties would include VA health care providers, peer review committee members, administrative investigation board members, factfinders, and facility leadership responsible for implementing procedures.
Sentiment
The available context suggests the bill is generally favorable and bipartisan in tone, as it was introduced by Representatives Dingell and Bergman and referred to the House Committee on Veterans’ Affairs and then the Subcommittee on Health without any recorded votes or committee debate in the provided materials. The bill’s framing emphasizes neutrality, accountability, and fairness in VA oversight, which typically attracts support from members concerned with patient safety and institutional integrity. No opposition is documented in the supplied record.
Contention
The main policy issue is how to balance effective internal quality review with protections against bias and self-review. The bill’s restrictions on participation by individuals involved in the underlying care, those with confidential quality assurance knowledge, or those with supervisory/personal relationships to the subject could be seen as strengthening impartiality, but they may also raise operational concerns about staffing, expertise, and the ability of VA facilities to assemble qualified review panels. No specific objections are recorded in the provided transcripts or votes, so any contention is inferred from the bill’s design rather than expressed debate.
Health: other; individualized investigational treatment for certain patients suffering from a life-threatening or severely debilitating illness; provide for. Amends title & secs. 1, 2, 3, 4, 5, 6 & 7 of 2014 PA 345 (MCL 333.26451 et seq.) & adds sec. 2a.